Relay Therapeutics, Inc.
SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of SHP2 phosphatase with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with SHP2 deregulation with the compounds and compositions of the disclosure.
Status:
Application
Type:
Utility
Filling date:
21 Feb 2019
Issue date:
17 Dec 2020